Ueda H - Search Results

1

Therapeutic benefits of 9-amino acid peptide derived from prothymosin alpha against ischemic damages.

Halder SK, Sugimoto J, Matsunaga H, Ueda H. Halder SK, et al. Among authors: ueda h. Peptides. 2013 May;43:68-75. doi: 10.1016/j.peptides.2013.02.022. Epub 2013 Mar 7. Peptides. 2013. PMID: 23499560

2

Morphine-induced overexpression of prepro-nociceptin/orphanin FQ in cultured astrocytes.

Takayama N, Ueda H. Takayama N, et al. Among authors: ueda h. Peptides. 2005 Dec;26(12):2513-7. doi: 10.1016/j.peptides.2005.05.005. Epub 2005 Jun 28. Peptides. 2005. PMID: 15990199

3

Evidence for serum-deprivation-induced co-release of FGF-1 and S100A13 from astrocytes.

Matsunaga H, Ueda H. Matsunaga H, et al. Among authors: ueda h. Neurochem Int. 2006 Aug;49(3):294-303. doi: 10.1016/j.neuint.2006.01.017. Epub 2006 Mar 7. Neurochem Int. 2006. PMID: 16519964

4

Voltage-dependent N-type Ca2+ channel activity regulates the interaction between FGF-1 and S100A13 for stress-induced non-vesicular release.

Matsunaga H, Ueda H. Matsunaga H, et al. Among authors: ueda h. Cell Mol Neurobiol. 2006 May;26(3):237-46. doi: 10.1007/s10571-006-9016-1. Epub 2006 Apr 21. Cell Mol Neurobiol. 2006. PMID: 16767511

5

Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures.

Ueda H, Fujita R, Yoshida A, Matsunaga H, Ueda M. Ueda H, et al. Among authors: ueda m. J Cell Biol. 2007 Mar 12;176(6):853-62. doi: 10.1083/jcb.200608022. J Cell Biol. 2007. PMID: 17353361 Free PMC article.

6

Synergistic Ca2+ and Cu2+ requirements of the FGF1-S100A13 interaction measured by quartz crystal microbalance: an initial step in amlexanox-reversible non-classical release of FGF1.

Matsunaga H, Ueda H. Matsunaga H, et al. Among authors: ueda h. Neurochem Int. 2008 May;52(6):1076-85. doi: 10.1016/j.neuint.2007.11.002. Epub 2007 Nov 21. Neurochem Int. 2008. PMID: 18164517

7

Prothymosin alpha plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke.

Ueda H. Ueda H. Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):315-23. doi: 10.1007/s00210-007-0254-7. Epub 2008 Jan 5. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18176798 Review.

8

Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage.

Ueda H. Ueda H. Pharmacol Ther. 2009 Sep;123(3):323-33. doi: 10.1016/j.pharmthera.2009.05.007. Epub 2009 Jun 3. Pharmacol Ther. 2009. PMID: 19500618 Review.

9

Endocrine disrupting chemicals bind to a novel receptor, microtubule-associated protein 2, and positively and negatively regulate dendritic outgrowth in hippocampal neurons.

Matsunaga H, Mizota K, Uchida H, Uchida T, Ueda H. Matsunaga H, et al. Among authors: ueda h. J Neurochem. 2010 Sep 1;114(5):1333-43. doi: 10.1111/j.1471-4159.2010.06847.x. Epub 2010 Jun 7. J Neurochem. 2010. PMID: 20534002 Free article.

10

Prothymosin alpha as robustness molecule against ischemic stress to brain and retina.

Ueda H, Matsunaga H, Uchida H, Ueda M. Ueda H, et al. Among authors: ueda m. Ann N Y Acad Sci. 2010 Apr;1194:20-6. doi: 10.1111/j.1749-6632.2010.05466.x. Ann N Y Acad Sci. 2010. PMID: 20536446 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,354 results

Search Page

Filters